We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+6.91%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$535M
AUM Growth
+$28M
Cap. Flow
+$20.7M
Cap. Flow %
3.87%
Top 10 Hldgs %
17.17%
Holding
336
New
30
Increased
83
Reduced
125
Closed
34

Top Buys

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$5.63M
2
MYGN icon
Myriad Genetics
MYGN
+$5.27M
3
AMBA icon
Ambarella
AMBA
+$4.33M
4
EVER icon
EverQuote
EVER
+$3.93M
5
AGX icon
Argan
AGX
+$3.72M

Sector Composition

Rank Sector Weight
1 Industrials 28.91%
2 Technology 24.08%
3 Healthcare 20.66%
4 Financials 5.77%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIO icon
226
Rio Tinto
RIO
$160B
$95.7K 0.02%
1,452
BMTX
227
DELISTED
BM Technologies, Inc.
BMTX
$95.4K 0.02%
+42,420
New +$96.8K
NTNX icon
228
Nutanix
NTNX
$17.7B
$93.1K 0.02%
1,637
-239
-13% -$14.7K
AXTA icon
229
Axalta
AXTA
$7.93B
$91.3K 0.02%
2,672
-394
-13% -$13.5K
ETON icon
230
Eton Pharmaceutcials
ETON
$1.18B
$89.7K 0.02%
27,252
-51,361
-65% -$180K
RRC icon
231
Range Resources
RRC
$9.32B
$87.7K 0.02%
2,616
-367
-12% -$13.2K
DXCM icon
232
DexCom
DXCM
$34.5B
$86.8K 0.02%
766
-105
-12% -$13.3K
ITRI icon
233
Itron
ITRI
$4.43B
$85.7K 0.02%
866
-120
-12% -$12.1K
TACT icon
234
Transact Technologies
TACT
$53M
$82.3K 0.02%
21,840
-41,368
-65% -$174K
DTE icon
235
DTE Energy
DTE
$28.9B
$81.6K 0.02%
735
SRCL
236
DELISTED
Stericycle Inc
SRCL
$80.2K 0.02%
1,380
-193
-12% -$9.91K
VERX icon
237
Vertex
VERX
$2B
$78.9K 0.01%
+2,189
New +$70.4K
DAIO icon
238
Data I/O
DAIO
$31.8M
$78.3K 0.01%
28,384
-53,606
-65% -$166K
RTX icon
239
RTX Corp
RTX
$296B
$78.1K 0.01%
778
GTES icon
240
Gates Industrial Corporation Ltd.
GTES
$7.01B
$75.7K 0.01%
4,788
-752
-14% -$12.8K
LPTH icon
241
Lightpath Technologies
LPTH
$836M
$73.6K 0.01%
58,397
-110,202
-65% -$150K
ALTR
242
DELISTED
Altair Engineering Inc
ALTR
$73.2K 0.01%
746
-108
-13% -$9.5K
FLS icon
243
Flowserve
FLS
$10.1B
$69.1K 0.01%
1,437
-199
-12% -$9.53K
CULP icon
244
Culp Inc
CULP
$43.9M
$68.3K 0.01%
15,246
-29,038
-66% -$129K
PXLW icon
245
Pixelworks
PXLW
$43.8M
$66.3K 0.01%
5,618
-10,618
-65% -$189K
ACA icon
246
Arcosa
ACA
$7.13B
$65.8K 0.01%
789
-114
-13% -$9.5K
CINF icon
247
Cincinnati Financial
CINF
$26.4B
$64.8K 0.01%
549
G icon
248
Genpact
G
$5.67B
$63.7K 0.01%
1,978
-310
-14% -$10K
GOOG icon
249
Alphabet (Google) Class C
GOOG
$4.2T
$58.7K 0.01%
320
WEX icon
250
WEX
WEX
$6.68B
$57.9K 0.01%
327
-46
-12% -$9.38K

Similar funds

Essex Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Essex Investment Management held 336 positions worth $535M, up 5.5% from $507M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Essex Investment Management deployed $20.7M of net new capital in Q2 2024, opening 30 new positions and adding to 83 existing holdings. Its largest new stake was Ligand Pharmaceuticals: 70,780 shares worth $5.96M.

By sector, the portfolio is most concentrated in Industrials at 29% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Aspen Aerogels, an estimated $2.12M trimmed.

  • Essex Investment Management's largest Q2 2024 buy was Ligand Pharmaceuticals: 70,780 shares worth $5.96M.
  • Essex Investment Management added most to AvePoint in Q2 2024, an estimated $3.22M increase.
  • Essex Investment Management's biggest Q2 2024 reduction was Aspen Aerogels, cutting an estimated $2.12M.
  • Essex Investment Management fully exited Digi International in Q2 2024, selling an estimated $7.01M.
  • Essex Investment Management's ten largest holdings make up 17% of its $535M portfolio in Q2 2024.
  • Essex Investment Management opened 30 new positions and closed 34 in Q2 2024.
  • Essex Investment Management's portfolio value rose 5.5% quarter-over-quarter to $535M.

Based on Essex Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.